Article ID Journal Published Year Pages File Type
8744693 Clinical Epidemiology and Global Health 2018 8 Pages PDF
Abstract
Pioglitazone use is associated with risk of BC in T2DM patients. Risk of bladder cancer appears to be associated with higher dose and longer duration of pioglitazone use.
Keywords
Related Topics
Life Sciences Immunology and Microbiology Virology
Preview
Pioglitazone and risk of bladder cancer in type 2 diabetes mellitus patients: A systematic literature review and meta-analysis of observational studies using real-world data
Authors
, , , , , ,